3-HO-PCE

Introduction

3-HO-PCE (3-Hydroxyphencyclidine) stands as a sophisticated arylcyclohexylamine compound representing significant interest in neuropharmacological research, particularly in studies examining NMDA receptor pharmacology and dissociative anesthetic mechanisms. As a hydroxylated metabolite and structural analog of PCE (phencyclidine), 3-HO-PCE offers researchers a unique tool for investigating structure-activity relationships within the arylcyclohexylamine chemical class. Biosynlab delivers analytical-grade 3-HO-PCE with certified ≥99.0% purity, supporting cutting-edge research across USA, United Kingdom, European Union, and international markets.

The hydroxylation at the 3-position of the cyclohexylamine ring fundamentally alters the compound’s physicochemical properties, metabolic profile, and receptor binding characteristics compared to the parent PCE molecule. This structural modification creates distinct pharmacological properties that make 3-HO-PCE invaluable for comparative studies with other arylcyclohexylamines including PCP, 3-MeO-PCE, O-PCE, and 3-HO-PCP. Biosynlab’s rigorous synthesis protocols and comprehensive analytical verification ensure researchers receive consistent, high-quality material essential for reproducible scientific outcomes.